Closed call · historical reference

H2020-JTI-IMI2-2020-23-two-stage · A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseases

Specific Challenge:Neurodegenerative diseases, and in particular Alzheimer’s disease (AD) and Parkinson’s disease (PD), represent a huge economic and societal burden. One of the key barriers to the development of treatments for neurodegenerative disease is an insufficient toolbox of biomarkers and…